News & Trends - Pharmaceuticals

Critical limits on dispensing of prescription and OTC medicines in response to COVID-19

Health Industry Hub | March 20, 2020 |
[Total: 1    Average: 5/5]

Pharma News: In order to ensure equitable access to medicines for all Australians, the Pharmacy Guild of Australia and the Pharmaceutical Society of Australia, in consultation with the Department of Health, are requiring community pharmacists to enforce new limits on dispensing and sales of prescription and over-the-counter medicines. This measure is also supported by the National Pharmaceutical Services Association, representing pharmaceutical wholesalers.

Demand for medicines increased markedly during the first two weeks of March in response to the COVID-19 pandemic. This resulted in pharmacies and wholesalers reporting numerous product lines out of stock. These temporary, local-level out-of-stocks have resulted in challenges for Australian consumers.

HCP engagement during COVID-19. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry.

According to the Therapeutic Goods Administration (TGA), Pharmaceutical companies report that if current levels of demand through excessive purchasing continue, supply interruptions will occur at both the national level while sponsors await scheduled deliveries of new stock from international manufacturing sites and at the local level as a result of stockpiling by pharmacy customers.

It is critical to protect the access of medicines for Australians. There will be certain requirements for community pharmacists, as follows:

  • Pharmacists will be required to limit dispensing of certain prescription products to 1 months’ supply at the prescribed dose, and sales of certain over-the-counter medicines to a maximum of one unit per purchase. These limits apply to particular classes of medicines for which unavailability or an interruption to treatment could result in significant health impacts. For example, prescription analgesics, anaphylaxis treatment, anti-arrhythmics, anti-hypertensives, anti-depressants, anti-epileptics and over-the-counter medicines such as glyceryl trinitrate, adrenaline autoinjectors and salbutamol inhalers (Ventolin).

  • Pharmacists will be strongly encouraged to limit dispensing and sales of all other medicines to one months’ supply or one unit. Dispensing of multiple repeats is permitted only for valid Regulation 49 prescriptions, which must only be written by prescribers. Two over-the-counter medicines for which there has been particularly high demand will be subject to new controls on the supply of these medicines:
  1. Salbutamol inhalers provided on an over-the-counter basis will be subject to new controls. Pharmacists will be required to confirm that supply is appropriate by confirmation of the patient’s diagnosis, label the product indicating to whom it has been dispensed and record the supply
  2. Pharmacists will be required to place paracetamol paediatric formulations behind the counter to assist in allocating supply equitably.

In addition, only one salbutamol or paracetamol paediatric product should be supplied per customer.

The Pharmacy Guild, the PSA and the National Pharmaceutical Services Association have agreed that these limits on pharmacy sales will be accompanied by limits on orders from wholesalers, to ensure equitable distribution of stock, including to regional and rural pharmacies.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Medical

Medical News - Paramedics Association concerned over uni students being thrown in to COVID-19 frontline

Paramedics Association concerned over uni students being thrown in to COVID-19 frontline

Health Industry Hub | April 1, 2020 |

The Australian Paramedics Association NSW (APA(NSW)) has significant concerns for the safety of patients, Paramedics and university students after NSW […]

More


News & Trends - Medical Technology

MedTech News - Australia's private hospitals join the COVID-19 fight in new partnership

Australia’s private hospitals join the COVID-19 fight in new partnership

Health Industry Hub | April 1, 2020 |

A new partnership with the Commonwealth Government will guarantee the viability of Australia’s private hospital sector, ensuring its full capacity […]

More


News & Trends - Pharmaceuticals

Pharma News - Roche's adjuvant treatment PBS listed in early breast cancer

Roche’s adjuvant treatment PBS listed in early breast cancer

Health Industry Hub | April 1, 2020 |

Effective 1st April 2020, Roche’s Kadcyla is listed on the Pharmaceutical Benefits Scheme (PBS), for the adjuvant treatment of patients […]

More


Leadership & Management

Leadership & Management - Bill Gates's insights on COVID-19 global pandemic

Bill Gates’s insights on COVID-19 global pandemic

Health Industry Hub | April 1, 2020 |

In a recent TED Talk, philanthropist and Microsoft co-founder Bill Gates offers insights into the COVID-19 pandemic, discussing why testing […]

More